Feb 6 (Reuters) - Indian drugmaker Aurobindo Pharma (ARBN.NS), opens new tab reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic ...

Aurobindo’s Eugia Pharma division has resumed shipping drugs from a plant in India that had to pause production in the wake of an FDA inspection. Eugia’s Unit III facility, which is located near ...

Aurobindo Pharma reported a 4% increase in net profit to Rs 848 crore for Q2, driven by strong sales in the US and Europe.

Jigar Patel says 25,700 will act as immediate support and 26,100 as resistance. He recommends short-term stocks include Oil ...

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has concluded an ...

() -Indian drugmaker Aurobindo Pharma reported a 3.8% rise in profit on Wednesday, helped by steady domestic demand, especially for its anti-retroviral drugs for HIV infections.

Aurobindo Pharma, MTAR Technologies, Zydus Wellness, and Muthoot Microfin are among the companies that will declare quarterly ...

BENGALURU (Reuters) - Aurobindo Pharma Ltd said on Thursday it would make and sell U.S.-based COVAXX's COVID-19 vaccine candidate for supply in India and to the United Nations Children's Fund (UNICEF) ...

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has issued an ...

India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for its specialty medicine portfolio. The Indian unit of British drugmaker GSK ...

India's Auro Realty, the real estate arm of Aurobindo Group which also owns drugmaker Aurobindo Pharma, is planning to raise 20 billion rupees ...

Ajit Mishra of Religare Broking recommends three stocks, including Grasim and Aurobindo Pharma. With favourable technical ...